Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | November 21, 2024 | November 25, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date November 21, 2024 · Filed November 25, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,514 |
Reported balance
After 2024-11-21 transaction · row 1
1 source rowRow 1 · 2024-11-21 · Grant · Acquired 2,200 · Balance 4,514 F1: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. |
| Common StockSEC Table I · non-derivative | IndirectBy Millon Family Trust | 107,703 |
Reported balance
Holding disclosure · report date 2024-11-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 107,703 |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 06, 2007 Filed Nov 8, 2007 21:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 23 | $41.82 | $961.86 |
DisclosureSEC source: 0000064803-07-000168 · doc.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,789 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 19:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 23 | $41.83 | $962.09 |
DisclosureSEC source: 0000064803-07-000161 · doc.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,766 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| September 26, 2007 Filed Sep 27, 2007 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 76 | $39.19 | $2,978.44 |
DisclosureSEC source: 0000064803-07-000154 · doc.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,743 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| July 11, 2007 Filed Jul 12, 2007 20:36 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 27 | $36.18 | $976.86 |
DisclosureSEC source: 0000064803-07-000137 · doc.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,667 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| June 26, 2007 Filed Jun 27, 2007 20:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 27 | $35.86 | $968.22 |
DisclosureSEC source: 0000064803-07-000129 · doc.xml · nonDerivative · entry 2 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,640 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| June 25, 2007 Filed Jun 27, 2007 20:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 27 | $36.31 | $980.37 |
DisclosureSEC source: 0000064803-07-000129 · doc.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,613 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| May 11, 2007 Filed May 14, 2007 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 8,946 | $37.30 | $333,685.80 |
DisclosureSEC source: 0000064803-07-000110 · doc.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,586 Read SEC document |
| May 09, 2007 Filed May 10, 2007 20:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 7,586 | $38.02 | $288,419.72 |
DisclosureSEC source: 0000064803-07-000103 · doc.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,532 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 33,726 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000066 · doc.xml · derivative · entry 6 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,726 Underlying: Common Stock · 33,726 shares Expires 2016-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000066 · doc.xml · derivative · entry 5 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,739 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 5,404 | $0.00 Strike: $18.05 | $0.00 |
DisclosureSEC source: 0000064803-07-000066 · doc.xml · derivative · entry 4 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,404 Underlying: Common Stock · 5,404 shares Expires 2014-04-30 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 22,960 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0000064803-07-000066 · doc.xml · derivative · entry 3 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,960 Underlying: Common Stock · 22,960 shares Expires 2011-12-20 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 8,946 | $34.80 | $311,320.80 |
DisclosureSEC source: 0000064803-07-000066 · doc.xml · nonDerivative · entry 2 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,260 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 32,314 | $34.80 | $1,124,527.20 |
DisclosureSEC source: 0000064803-07-000066 · doc.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,314 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 23:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 33,726 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000073 · doc.xml · derivative · entry 6 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,726 Underlying: Common Stock · 33,726 shares Expires 2016-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 23:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000073 · doc.xml · derivative · entry 5 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,739 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 23:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 5,404 | $0.00 Strike: $18.05 | $0.00 |
DisclosureSEC source: 0000064803-07-000073 · doc.xml · derivative · entry 4 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,404 Underlying: Common Stock · 5,404 shares Expires 2014-04-30 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 23:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 22,960 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0000064803-07-000073 · doc.xml · derivative · entry 3 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,960 Underlying: Common Stock · 22,960 shares Expires 2011-12-20 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 23:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 32,314 | $34.80 | $1,124,527.20 |
DisclosureSEC source: 0000064803-07-000073 · doc.xml · nonDerivative · entry 2 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Millon Family Trust Disclosed balance after: 32,314 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 23:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 8,946 | $34.80 | $311,320.80 |
DisclosureSEC source: 0000064803-07-000073 · doc.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,946 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.